🔗 Share this article

Given that the US undertakes unprecedented changes to its vaccination schedules, one figure appears somewhat surprisingly: Høeg, a US-based sports physician and epidemiologist who initially gained attention by questioning coronavirus shots in the pandemic and has focused upon alleged fatalities after Covid immunization in her recent position at the US Food and Drug Administration (FDA).

Proposed Overhauls to Pediatric Immunization Schedule

Health officials had intended to reveal radical changes to the pediatric immunization program in December, bringing the US with the Danish immunization schedule, it is understood – a major change that would place the US out of step with a large portion of the international standard with no evidence for public health gain. The announcement has been delayed until the next year.

Rather than the top vaccines chief, Tracy Beth Høeg is listed to speak at the event. She was just designated temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to run the center this year.

Consolidating Power at the Regulatory Body

The acting appointment may indicate a closer partnership between the drug and biologics branches as Høeg and Dr. Prasad solidify control at the regulatory agency – and it points to a greater focus upon rolling back already-approved immunizations at the FDA.

Høeg has often pushed for discontinuing some pediatric vaccine recommendations in the US to become more in line with Denmark, a nation with comprehensive healthcare and a number of inhabitants about the population of the state of Wisconsin.

In her initial public appearances, she has continued to focus on vaccination policy – usually the domain of Prasad, head of the FDA’s CBER – rather than pharmaceutical oversight.

Doubts Over Expertise

Dr. Høeg has little discernible experience in pharmaceutical research, regulation or administrative roles, which has been standard for past directors of the biologics center. She has served at the FDA as a key advisor to the commissioner and the vaccine center since March.

“She appears not to have any of the qualifications” for leading the drug-regulation department, said Dr. Jonathan Howard. “She lacks experience running a scientific study. She has no expertise in managing a large organization. She is not an expert in industry regulation.”

Previous commissioners of the center would “grasp laws and regulations and the research of drug development”, noted Dr. Janet Woodcock. “Clearly, she has not acquired the type of experience that previous people who led CBER have had.”

The drug center has an vast portfolio at the agency, she emphasized.

“Many people just zeroes in on the innovative therapies, but the off-patent medication office approves a multitude of generic drugs. There is also a biosimilars division, over-the-counter program and other areas, and all of those must be supervised,” she said. “The responsibility you overlook, that’s the thing that I always told people is going to bite you.”

Additionally, a significant administrative component to the role, which supervises in excess of 5,000 personnel. “It’s a enormous administrative position, if you do it right,” the former official concluded.

Response and Disputed Policies

When asked about inquiries about Dr. Høeg's fitness for the role and whether this appointment represents more teamwork among agency officials on immunizations, a spokesperson stated that the “concerns are based on incorrect assumptions”.

“This background is consistent with the duties of her job,” the representative explained, citing the months Dr. Høeg spent counseling the agency head on “medication safety and regulatory science, including computational safety modeling and vaccine surveillance”.

In her interim role, Dr. Høeg takes over the commissioner’s recently launched expedited review system, a controversial one-day medication authorization process that reportedly troubled her former heads. “By what process are these therapies being chosen for this expedited pathway? Who is making the calls?” Howard questioned. “There is a lot of lack of transparency going on at the FDA right now.”

Overall, he remarked, “the agency seems to be moving towards less stringent regulations of most medications, with the exception of immunizations.”

Documented History on Vaccines

With immunizations, Høeg has a more established, if problematic, history, Howard said. She authored a analysis using non-validated volunteer-provided data to determine the frequency of heart inflammation after Covid vaccination. She advised the Florida chief medical officer Dr. Joseph Ladapo, who reportedly have changed statistics to indicate Covid vaccinations are more dangerous than they are.

Included in her “wish list” for the current government featured revising rules for recently developed shots and discontinuing “non-essential” vaccines, she remarked post-election on a online show. At the agency, Dr. Høeg has according to sources floated the idea of preventing teenage boys from receiving Covid vaccines.

“She is an thorough true believer who begins with her beliefs and works backwards to accommodate the science in a highly disingenuous, untruthful way,” Howard stated.

Gaining Influence and a “Campaign of Retribution”

Dr. Høeg aligned with other contrarians, {like|